NZ208013A - Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora - Google Patents

Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora

Info

Publication number
NZ208013A
NZ208013A NZ208013A NZ20801384A NZ208013A NZ 208013 A NZ208013 A NZ 208013A NZ 208013 A NZ208013 A NZ 208013A NZ 20801384 A NZ20801384 A NZ 20801384A NZ 208013 A NZ208013 A NZ 208013A
Authority
NZ
New Zealand
Prior art keywords
bbm
exhibits
methanol
strain
silica gel
Prior art date
Application number
NZ208013A
Other languages
English (en)
Inventor
M Konishi
K Saitoh
H Ohkuma
H Kawaguchi
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ208013A publication Critical patent/NZ208013A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ208013A 1983-05-16 1984-05-01 Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora NZ208013A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49523183A 1983-05-16 1983-05-16

Publications (1)

Publication Number Publication Date
NZ208013A true NZ208013A (en) 1987-07-31

Family

ID=23967812

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ208013A NZ208013A (en) 1983-05-16 1984-05-01 Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora

Country Status (28)

Country Link
JP (2) JPS59232094A (fr)
KR (2) KR840008817A (fr)
AT (1) AT393691B (fr)
AU (1) AU569294B2 (fr)
BE (1) BE899667A (fr)
CA (1) CA1241282A (fr)
CY (1) CY1465A (fr)
DE (1) DE3418023A1 (fr)
DK (1) DK163127C (fr)
ES (1) ES8700267A1 (fr)
FI (1) FI81114C (fr)
FR (1) FR2547594B1 (fr)
GB (1) GB2141425B (fr)
GR (1) GR81581B (fr)
HK (1) HK9889A (fr)
HU (1) HU193928B (fr)
IE (1) IE57444B1 (fr)
IL (1) IL71824A (fr)
IT (1) IT1175498B (fr)
KE (1) KE3846A (fr)
LU (1) LU85362A1 (fr)
NL (1) NL8401572A (fr)
NZ (1) NZ208013A (fr)
PT (1) PT78590A (fr)
SE (1) SE460364B (fr)
SU (1) SU1344249A3 (fr)
YU (1) YU43846B (fr)
ZA (1) ZA843591B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78648B (fr) * 1982-07-26 1984-09-27 Bristol Myers Co
IL79519A0 (en) * 1985-08-27 1986-10-31 Bristol Myers Co Bbm-1675c and d antitumor antibiotics
US4837206A (en) * 1987-04-29 1989-06-06 Bristol-Myers Company Esperamicin derivatives
US4996305A (en) * 1988-02-29 1991-02-26 American Cyanamid Company Process for producing the antibiotic and antitumor agents LL-E33288.epsilon.ε-Br
CA2027601A1 (fr) * 1989-11-06 1991-05-07 Koko Sugawara Antibiotique antitumeur bu-3983t
US20240075407A1 (en) * 2021-03-17 2024-03-07 Nissui Corporation Method of purification and purified products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195079A (en) * 1979-01-31 1980-03-25 Pfizer Inc. New polycyclic ether antibiotic
JPS56113791A (en) * 1980-02-15 1981-09-07 Kaken Pharmaceut Co Ltd Novel antibiotic and its preparation
GR78648B (fr) * 1982-07-26 1984-09-27 Bristol Myers Co
US4539203A (en) * 1984-11-13 1985-09-03 Warner-Lambert Company CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use

Also Published As

Publication number Publication date
GB8412368D0 (en) 1984-06-20
SE8402619D0 (sv) 1984-05-15
GR81581B (fr) 1984-12-11
IT1175498B (it) 1987-07-01
DK163127C (da) 1992-06-09
LU85362A1 (fr) 1985-03-21
ZA843591B (en) 1985-02-27
AT393691B (de) 1991-11-25
JPH02128693A (ja) 1990-05-17
GB2141425B (en) 1986-12-03
IT8420928A1 (it) 1985-11-15
FI841906A (fi) 1984-11-17
HUT37168A (en) 1985-11-28
FI841906A0 (fi) 1984-05-11
KR920001366B1 (ko) 1992-02-11
SE8402619L (sv) 1984-11-17
GB2141425A (en) 1984-12-19
DK239784D0 (da) 1984-05-15
ATA160984A (de) 1991-05-15
CY1465A (en) 1989-07-21
FR2547594B1 (fr) 1988-03-25
KE3846A (en) 1989-04-07
HU193928B (en) 1987-12-28
IL71824A0 (en) 1984-09-30
AU569294B2 (en) 1988-01-28
YU84984A (en) 1988-04-30
AU2779184A (en) 1984-11-22
SE460364B (sv) 1989-10-02
IE841200L (en) 1984-11-16
ES8700267A1 (es) 1986-09-16
DK163127B (da) 1992-01-20
FR2547594A1 (fr) 1984-12-21
DE3418023C2 (fr) 1988-08-18
FI81114C (fi) 1990-09-10
SU1344249A3 (ru) 1987-10-07
JPH0555111B2 (fr) 1993-08-16
CA1241282A (fr) 1988-08-30
JPH0229079B2 (fr) 1990-06-27
YU43846B (en) 1989-12-31
NL8401572A (nl) 1984-12-17
ES532476A0 (es) 1986-09-16
HK9889A (en) 1989-02-10
JPS59232094A (ja) 1984-12-26
IE57444B1 (en) 1992-09-09
FI81114B (fi) 1990-05-31
DK239784A (da) 1984-11-17
DE3418023A1 (de) 1984-11-22
IL71824A (en) 1988-09-30
BE899667A (fr) 1984-11-16
KR840008817A (ko) 1984-12-19
KR900019562A (ko) 1990-12-24
PT78590A (en) 1984-06-01
IT8420928A0 (it) 1984-05-15

Similar Documents

Publication Publication Date Title
US4675187A (en) BBM-1675, a new antibiotic complex
US4518589A (en) BBM-2478 Antibiotic complex
US4524145A (en) 4'-Deschlororebeccamycin pharmaceutical composition and method of use
EP0095154A1 (fr) Substances biologiquement actives dénommées WS 6049, leur procédé de préparation et leurs compositions pharmaceutiques
US4582639A (en) Antitumor antibiotic compound
NZ208013A (en) Antitumour antibiotic bbm-1675 and production by cultivating actinomadura verrucosospora
CA1093998A (fr) Baumycine, complexe autibiotique-antitumoral et composes le contenant
AU633826B2 (en) Bu-3420t antitumor antibiotic
US4792522A (en) Rigolettone antitumor complex
US4598145A (en) Albacarcins V and M
CA1210350A (fr) Culture bacterienne produisant un complexe antibiotique
US4708872A (en) Antitumor antibiotic complex
US4626503A (en) Antitumor agents LL-D49194α1, LL-D49194β1, LL-D49194β2, LL-D49194β3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω1, LL-D49194ω2, and LL-D49194ω3
US4599310A (en) Process for producing antitumor antibiotic compound
US4868117A (en) BBM-1675, a new antitumor antibiotic complex
US4301248A (en) Fermentation process for making rachelmycin
US4461831A (en) Antitumor agents albacarcins V and M
US4572895A (en) Process for preparing an antibiotic complex by culturing actinomyces strain ATCC 39417
EP0213320B1 (fr) Formamides physiologiquement actifs
US5021549A (en) Physiologically active substances, probestin and prostatin and production thereof
EP0157203A2 (fr) Agents antitumoraux LL-D49194 alpha 1, LL-D49194 bêta 1, LL-D49194 bêta 2, LL-D49194 bêta 3, LL-D49194 gamma, LL-D49194 delta, LL-D49194 epsilon, LL-D49194 dzéta, LL-D49194 êta LL-D499194 oméga 1, LL-D49194 oméga 2 et LL-D49194 oméga 3
US4956374A (en) Polysubstituted thiazolylpyridine carboxyamide antifungal antibiotic
EP0025713B1 (fr) Antibiotique de la série de l'anthracycline et composition pharmaceutique le contenant
CH663155A5 (en) Antitumour antibiotics
EP0657467A1 (fr) Antibiotiques antitumoraux